BioCentury

BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Vizitează neapărat site-ul podcastului și susține-i creatorul: www.biocentury.com

Autor

BioCentury

Categorie

Science

Site-ul podcastului

www.biocentury.com

Cel mai nou episod

13 oct. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android aproape 10 mil. descărcări · nota 4,8 iOS în curând

Episoade

Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval 30.08.2021

Reach us by sending a text

Ep 76 Pt. 1 - Accelerated Approval's Big Picture 30.08.2021

Reach us by sending a text

Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium 24.08.2021

Reach us by sending a text

Ep. 74 - Vertex's Road Map & Innovation in MS 16.08.2021

Reach us by sending a text

Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat 13.08.2021

Reach us by sending a text

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD 09.08.2021

Reach us by sending a text

Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap 03.08.2021

Reach us by sending a text

Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen 29.07.2021

Reach us by sending a text

Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer 27.07.2021

Reach us by sending a text

Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends 20.07.2021

Reach us by sending a text

Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning 13.07.2021

Reach us by sending a text

Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap 06.07.2021

Reach us by sending a text

Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm 29.06.2021

Reach us by sending a text

Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint 24.06.2021

Reach us by sending a text

Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast 21.06.2021

Reach us by sending a text

Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast 14.06.2021

Reach us by sending a text

Ep. 61 - Dissecting FDA's Aducanumab Decision 08.06.2021

Reach us by sending a text

Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021

Reach us by sending a text

Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021

Reach us by sending a text

Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021

Reach us by sending a text

Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021

Reach us by sending a text

Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021

Reach us by sending a text

Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021

Reach us by sending a text

Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021

Reach us by sending a text

Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview 13.04.2021

Reach us by sending a text

Ascultă podcastul BioCentury This Week în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice